Opaque intraocular lens for
intractable diplopia-UK survey.
(Implant intraoculaire opaque contre la diplopie incoercible - une étude
britannique)
Kwok T, Watts P.
University Hospital of Wales, Cardiff, UK.
AIMS: To assess
the practice of the use of an opaque intraocular lens (IOL) for intractable
diplopia in the UK.
METHODS: A questionnaire was sent to 892 consultant ophthalmologists in
practice requesting information on the treatment of intractable diplopia with an
opaque IOL. Respondents were asked whether they would consider using an opaque
IOL for intractable diplopia. Information was gathered on the numbers of lenses
implanted, the type of lens used, and whether the lens was implanted inside or
outside the capsular bag. In addition, we asked for the causes of intractable
diplopia, the success in eliminating diplopia, the use of postoperative
pilocarpine, and whether postoperative surveillance was part of the follow-up
protocol.
RESULTS: Of the 481 completed questionnaires received, 72% would consider
implanting an opaque IOL. A total of 48 surgeons had implanted 1 or more lenses.
There were 97 patients who were implanted with an opaque IOL over the past 15
years. Strabismus, nerve palsies, and previous retinal detachment surgery with
diplopia were the main indications. Pseudophakic lenses were used by 38 surgeons
in the capsular bag, 6 used iris-supported phakic lenses, and 2 used phakic
lenses in the anterior chamber angle. The use of postoperative pilocarpine was
reported by 9 surgeons, and 6 surgeons used regular ultrasound fundal
surveillance. Patients were reported to be completely asymptomatic at discharge
by 31 surgeons, with 15 surgeons reporting patients who were still symptomatic
postoperatively. Only 1 intraoperative complication was reported.
CONCLUSIONS: An opaque IOL is a safe method for treating intractable
diplopia. This survey confirms that its practice is widely accepted in the UK.
Retour à la bibliographie d'Octobre 2009
(Dernière mise à jour de cette page le 27/08/10)